Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate
Bw. Henderson et al., Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate, CANCER RES, 60(3), 2000, pp. 525-529
At high fluence rates in animal models, photodynamic therapy (PDT) can phot
ochemically deplete ambient tumor oxygen through the generation of singlet
oxygen, causing acute hypoxia and limiting treatment effectiveness. We repo
rt that standard clinical treatment conditions (1 mg/kg Photofrin, light at
630 nm and 150 mW/cm(2)), which are highly effective for treating human ba
sal cell carcinomas, significantly diminished tumor oxygen levels during in
itial light delivery in a majority of carcinomas. Oxygen depletion could be
found during at least 40% of the total light dose, hut tumors appeared wel
l oxygenated toward the end of treatment. In contrast, initial light delive
ry at a lower fluence rate of 30 mW/cm(2) increased tumor oxygenation in a
majority of carcinomas. Laser treatment caused an intensity- and treatment
time-dependent increase in tumor temperature. The data suggest that high fl
uence rate treatment, although effective, may be inefficient.